The Future of Nutrigenomics: New opportunities in personalized nutrition and food-pharma collaboration
Business Insights
January 1, 2010 151 Pages - SKU: RET2578689
|
|
Nutrigenomics explores how nutrients or bioactive dietary compounds can influence gene expression and an individuals risk to certain diseases. Nutrigenetics is the study of how variations in an individual’s genetic makeup can increase or decrease the need for a specific nutrient or bioactive food component.
Nutrigenomics has the potential to impact various parts of the food chain including the genetic modification of crops and animal feeds, the development of nutrigenomic tests to monitor food safety and personalization of diets, as well as the identification of nutritional supplements and nutrigenomic based products which may offer potential health benefits. The consumer environment is driving growth in the Nutrition & Health market.
Over the past decade, consumers have become more concerned for their health and are increasingly inclined to invest in DTC nutrigenetic tests to assess their risk of disease and obtain dietary advice. Healthcare providers too, are keen to shift some of the burden of healthcare costs to individuals and recognize that the personalization of nutrition may be beneficial. The Health and nutrition market is currently worth around $485 billion.
This report reviews the business strategies of leading companies regarding the adoption of nutrigenomic technologies and establishment of public-private partnerships as well as potential opportunities for biomarker discovery with the pharma and diagnostic industry to personalize nutrition and medicine.
|
- The Future of Nutrigenomics
- Executive summary
- Defining nutrigenomics
- Market drivers
- Collaborative nutrigenomic research & consortia
- Leading food & drinks companies: nutrigenomic strategies
- Leading nutrigenomic testing companies
- Opportunities: convergence of pharma & diagnostics
- Challenges: regulation, ethical & IP issues
- Conclusions
- Chapter 1 Defining nutrigenomics
- Summary
- Introduction
- ‘Omic technologies
- Nutrigenomics and the food & drinks industry
- Nutrigenomics & food products
- Nutrigenomics & personalized nutrition
- Report outline
- Chapter 2 Market drivers
- Summary
- Introduction
- Drivers for personalized nutrition
- Healthy aging
- Consumer demographics
- Chronic non-communicable disease
- Urbanization and the emerging markets
- Global health economics
- Conclusions on drivers for personalized nutrition
- Chapter 3 Collaborative nutrigenomic research & consortia
- Summary
- Introduction
- Nutrigenomic research consortia
- Nutrigenomic research in the EU
- The European Nutrigenomics Organization (NuGO)
- DiOGenes
- TI Food and Nutrition
- Vision EpiFood Project
- Canada Foundation for Innovation (CFI)
- Public-private in age-related diseases
- Nutrigenomic research in the US
- Public-private partnership: genetically modified crops
- Nutrigenomic research across the world
- International Society of Nutrigenetics/Nutrigenomics (ISNN)
- Conclusions
- Chapter 4 Leading food & drinks companies: nutrigenomic strategies
- Summary
- Introduction
- Ingredients manufacturers approach to nutrigenomics
- BASF
- Chr Hansen
- DSM
- Food manufacturers’ approach to nutrigenomics
- Group Danone
- Nestlé
- Unilever
- Pharma industry M&A in consumer nutrition
- The evolving open network model
- Co-development opportunities
- Areas for market growth & time scales
- Conclusions
- Chapter 5 Leading nutrigenomic testing companies
- Summary
- Introduction
- Market leaders
- 23andme.com
- GeneLink
- Gene Smart
- Genova Diagnostics
- Interleukin Genetics Inc
- WellGen Inc.
- Conclusions
- Chapter 6 Opportunities: convergence of pharma & diagnostics
- Summary
- Introduction
- Nutrigenomics vs pharmacogenomics
- Global health issues treatment vs prevention
- Convergence of the pharmaceutical & diagnostic market
- Conclusions
- Chapter 7 Challenges: regulation, ethical & IP issues
- Summary
- Introduction
- Regulation of nutrigenomic foods
- Europe
- Japan
- Regulation of nutrigenomic tests
- Ethical issues
- Public awareness & perceptions
- Intellectual Property
- Conclusions
- Chapter 8 Conclusions
- Summary
- The food & drinks market
- Global genetic testing market
- Market trends
- Overall conclusions
- Appendix
- Primary research methodology
- Acknowledgments
- Glossary
- Index
- Bibliography
- Endnotes
- List of Figures
- Figure 1.1: Nutrigenetics and nutrigenomics
- Figure 1.2: The ‘omics technologies
- Figure 1.3: The functional genomic tool box
- Figure 1.4: Applications of nutrigenomics in the food chain
- Figure 2.5: Drivers for the food & drinks industry
- Figure 2.6: The ageing population a driver for personalized nutrition
- Figure 2.7: Personalized nutrition targeting consumer segments
- Figure 2.8: Population over 60: world and developed regions (1950-2050)
- Figure 2.9: Nutritional challenges - obesity & metabolic syndrome
- Figure 2.10: Growth in consumers in developing & emerging countries (2008-2018)
- Figure 2.11: Healthcare expenditure as a share of GDP (2006)
- Figure 2.12: Target population of nutrigenomic based products
- Figure 4.13: BASF approach to gene discovery
- Figure 4.14: DSMs sales growth targeting four emerging business areas
- Figure 4.15 DSMs R&D competencies
- Figure 4.16 An International and interdisciplinary network
- Figure 4.17 Diversify & de-risk through externalization
- Figure 4.18 Open network model
- Figure 4.19: Waves of nutrigenomic development
- Figure 5.20: WellGen’s nutrigenomic based discovery
- Figure 6.21: Nutrigenomics vs pharmacogenomics
- Figure 6.22: Relationship of drugs, disease, genes and gene products
- Figure 8.23: Health and nutrition market segments (2009)
- Figure 8.24: Nutrigenomic impact on personalized nutrition
- List of Tables
- Table 3.1: European Consortia and Nutrigenomic Research Programs
- Table 3.2: Nutrigenomics Network Programs
- Table 4.3: Stakeholders in nutrigenomic research and personalized nutrition
- Table 4.4: Chr Hansen - strategic alliances & investments
- Table 4.5: Nestlé nutrigenomic alliances & investments
- Table 4.6: Divestment of Animal, Consumer & Medical Nutrition Divisions
- Table 4.7: Consumer Health Divisions of Pharmaceutical Companies
- Table 4.8: Alliance between Food, Pharma, Biotech and the Diagnostic Industries
- Table 5.9: Categorization of genetic variations that may be included in nutrigenomic tests
- Table 5.10: Categorization of genetic variations that may be included in nutrigenomic tests
- Table 6.11: Known diet- gene interactions
- Table 6.12: Known gene-nutrient interactions
Share this report
Other tasks Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
